Shares of Zogenix, Inc. (Nasdaq:ZGNX), are up more than 5% to $1.42 in after-hours trading Friday following the company's announcement that the FDA has approved a new formulation of Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules, ... Wall Street Pit, 11 hours ago
Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER - Wall Street Select, 13 hours ago
PDUFA date approaches for Zohydro sNDA - Seeking Alpha, 2 days ago
1 images for "Zohydro"
Reports Outline FDA Actions Findings from Harvard University [Zohydro ? Approval by Food and Drug Administration: Controversial or Frightening?]
By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on FDA Actions. According to news reporting out of Boston, Massachusetts, by NewsRx editors, research stated, "The actions and regulations of the Food and Drug ...Pharmacy Choice, 1 month ago
The FDA has faced a firestorm of criticism since approving Zogenix's ($ZGNX) superstrength painkiller Zohydro last year, drawing outcry from lawmakers and industry groups concerned with the drug's all-hydrocodone formula with no features to deter ...FiercePharma, 2 months ago Purdue wins a pain pill approval with Zohydro in its crosshairs FierceBiotech, 2 months ago FDA approves abuse-resistant hydrocodone painkiller, offering alternative to Zohydro Yahoo! Canada, 2 months ago Purdue Pharma Wins U.S. Approval for Abuse-Deterrent Painkiller Washington Post, 2 months ago
Zogenix (NASDAQ:ZGNX) s stock had its buy rating reaffirmed by analysts at Brean Capital in a research report issued to clients and investors on Tuesday. Shares of Zogenix ( NASDAQ:ZGNX ) opened at 1.31 on Tuesday. Zogenix has a 1-year low of ...SleekMoney, 1 week ago Brean Capital Initiates Coverage On Zogenix Benzinga.com, 1 month ago
What's wrong with America is what's wrong with Big Pharma. And what's wrong with Big Pharma is what's wrong with America. This circular reality is aimed to be thoroughly covered in this presentation. This is the story of how Big Pharma seeks ...Global Research, 1 week ago
It has been a very bumpy start to the New Year for investors as volatility has increased substantially. Oil prices continue to plunge and the U.S. dollar continues to strengthen, roiling sectors of the market. However, that doesn't change the fact ...Investors Alley, 2 weeks ago
Action Points Deaths due to poisoning from prescription opioids rose in 2013 as did heroin deaths, despite years of policy changes and increasing awareness of abuse and addiction. Note that the data showed a rise in both prescriptions and abuse ...MedPage Today, 2 weeks ago
It's a new season of The Wendy Williams show. Hosted by the unique and entertaining Wendy Williams this talk show features a mix of celebrity interviews and performances with guests from TV, film, music and sports. During the popular segments "Ask ...Business Ghana, 3 weeks ago
Zogenix 2015 Expectations and Developments Drive Price Upward: Analyst Report Issued by BrokerBank Securities, Inc.
NEW YORK , Jan. 5,2015 /PRNewswire/ --Zogenix Inc. ( NASDAQ: ZGNX ) is a California -based pharmaceutical company that develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company's two main ...Tamar Securities, 3 weeks ago
FDA announced in November 2014 the approval of an extended-release, once-daily hydrocodone product (Hysingla ER—Purdue Pharma) with abuse-deterrent properties. The product is the fourth recognized by FDA as having tamper-resistant ...Pharmacist.com, 4 weeks ago FDA approves Hysingla with abuse-deterrent properties Pharmacist.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!